Clinical Trial Update: Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of additional chemotherapy after concurrent chemoradiation in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: COMPLETED